Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase.

Authors: Zhou, Xue; Sun, Hong; Chen, Haobin; Zavadil, Jiri; Kluz, Thomas; Arita, Adriana; Costa, Max

Published In Cancer Res, (2010 May 15)

Abstract: Histone H3 lysine 4 (H3K4) trimethylation (H3K4me3) at the promoter region of genes has been linked to transcriptional activation. In the present study, we found that hypoxia (1% oxygen) increased H3K4me3 in both normal human bronchial epithelial Beas-2B cells and human lung carcinoma A549 cells. The increase of H3K4me3 from hypoxia was likely caused by the inhibition of H3K4 demethylating activity, as hypoxia still increased H3K4me3 in methionine-deficient medium. Furthermore, an in vitro histone demethylation assay showed that 1% oxygen decreased the activity of H3K4 demethylases in Beas-2B nuclear extracts because ambient oxygen tensions were required for the demethylation reaction to proceed. Hypoxia only minimally increased H3K4me3 in the BEAS-2B cells with knockdown of JARID1A, which is the major histone H3K4 demethylase in this cell line. However, the mRNA and protein levels of JARID1A were not affected by hypoxia. GeneChip and pathway analysis in JARID1A knockdown Beas-2B cells revealed that JARID1A regulates the expression of hundreds of genes involved in different cellular functions, including tumorigenesis. Knocking down of JARID1A increased H3K4me3 at the promoters of HMOX1 and DAF genes. Thus, these results indicate that hypoxia might target JARID1A activity, which in turn increases H3K4me3 at both the global and gene-specific levels, leading to the altered programs of gene expression and tumor progression.

PubMed ID: 20406991 Exiting the NIEHS site

MeSH Terms: Biomarkers/metabolism; Blotting, Western; Bronchi/enzymology*; Bronchi/pathology; Cells, Cultured; Chromatin Immunoprecipitation; DNA Methylation*; Epithelial Cells/enzymology*; Epithelial Cells/pathology; Gene Expression Profiling; Heme Oxygenase-1/genetics; Heme Oxygenase-1/metabolism; Histones/metabolism*; Humans; Hypoxia-Inducible Factor 1, alpha Subunit/genetics; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism; Lung Neoplasms/enzymology*; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Lysine/genetics*; Lysine/metabolism; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic/genetics; RNA, Messenger/genetics; RNA, Messenger/metabolism; RNA, Small Interfering/pharmacology; Retinoblastoma Protein/metabolism; Retinoblastoma-Binding Protein 2/antagonists & inhibitors*; Retinoblastoma-Binding Protein 2/genetics; Retinoblastoma-Binding Protein 2/metabolism; Reverse Transcriptase Polymerase Chain Reaction

to Top